Clinical Impact of Patient Adherence to a Fixed-Dose Combination of Olmesartan, Amlodipine and Hydrochlorothiazide

  • Peter Bramlage, Reinhard Ketelhut, Eva-Maria Fronk, Wolf-Peter Wolf, Rüdiger Smolnik, Claudia Zemmrich, Roland E. Schmieder
  • Clinical Drug Investigation, April 2014, Springer Science + Business Media
  • DOI: 10.1007/s40261-014-0188-z

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage